Skip to content

With more than 20 years’ expertise in phage display, IRBM applies its extensive antibody libraries to discover lead therapeutic candidates. With your project goals as our focus, we’ll develop a bespoke strategy and employ the combination of our antibody library (containing more than 6×1010 clones), affinity maturation libraries and deep characterization of IgGs, to ensure your selected antibody candidates are fit-for-purpose.

IRBM boasts an extensive suite of antibody characterisation assays, from assessing kinetic parameters using biophysical approaches, to epitope binning, cell based functional assays and in vivo studies, including efficacy in xenograft models.

FIND OUT HOW WE CAN SUPPORT YOUR ANTIBODY DISCOVERY PROGRAM:

ANTIBODY
PHAGE DISPLAY

ANTIBODY
CHARACTERISATION

BIOPHYSICAL
AND FUNCTIONAL
ASSAYS

PK/PD

Back To Top